[ET Net News Agency, 16 February 2024] SINO BIOPHARM (01177) rose 3.1% to HK$3.04.
It hits an intra-day high of HK$3.04, and an intra-day low of HK$2.96. The total shares
traded was 4.1 million, with a value of HK$12.27m. The active buy/sell ratio is 59:41,
with net buying turnover of HK$1.73m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$693,680, with volume weighted average price of HK$2.982.
BNP PARIBAS SEC (ASIA) accounts for greatest net responsive selling turnover of
HK$799,540, with volume weighted average price of HK$2.97. The stock has risen a combined
4.5% over the past 3 consecutive trading days.
The Hang Seng Index now rose 81 points, or 0.5% to 16,026; the Hang Seng China
Enterprises Index now rose 27 points, or 0.5% to 5,438.
Basic Information
=================
--------------------------------
Nominal 3.040 % Chg +3.05%
High 3.040 Low 2.960
Shares Tr 4.1m Turnover 12.27m
10-D SMA 2.933 %H.V 45.840
20-D SMA 2.926 VWAP 2.989
50-D SMA 3.149 RSI14 51.660
--------------------------------
Status: Active buy/sell ratio is 59:41, with net buying turnover of HK$1.73m, rising a
combined 4.5% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
SINO BIOPHARM (01177) 3.04 +3.05
ALI HEALTH (00241) 3.22 +0.62
CSPC PHARMA (01093) 6.05 +1.00
SINOPHARM (01099) 20.55 -0.24
WUXI APPTEC (02359) 38.45 -1.54
CHINARES PHARMA (03320) 4.92 +0.82
HANSOH PHARMA (03692) 13.08 +0.93
SCICLONE PHARMA (06600) 11.18 -2.10
JD HEALTH (06618) 29.00 +0.69
GOLDEN THROAT (06896) 3.39 -1.45
-----------------------------------------------
(ed)